On June 17, MicroPort Robot-B rose 5.54% in regular trading, trading at 22.82 HKD/share, with turnover of 19.8984 million HKD, reversing its prior consecutive pullback trend.

On the news front, the company announced that its core product, the Toumai laparoscopic surgical robot, has surpassed 300 units in global commercial orders, with the group's cumulative total orders approaching 400 units. Notably, new orders secured in the first half already exceeded the full-year total from last year, demonstrating strengthening market competitiveness and brand influence. The company has achieved commercial installation in over 60 countries and regions, with particularly robust order performance in emerging markets including India, Brazil, and Argentina.

The milestone order breakthrough effectively offset prior market concerns over competitive pressure from Intuitive Surgical's next-generation da Vinci 5 system, which added 232 new installations in Q1 with year-over-year doubling growth. The broader Health Care Equipment sector showed mixed performance, with MICROPORT up 2.15%, Modern Dental up 1.54%, and Lifetech Scientific up 0.66%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)